Cargando…
NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin
Nucleotide-binding oligomerization domain, leucine rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome has been implicated in a series of physiological and pathological processes. However, its correlation in coronary heart disease (CHD) still remains to be elucidated. The present...
Autores principales: | Zhu, Jian, Wu, Shili, Hu, Sigan, Li, Hui, Li, Miaonan, Geng, Xu, Wang, Hongju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625427/ https://www.ncbi.nlm.nih.gov/pubmed/31257469 http://dx.doi.org/10.3892/mmr.2019.10382 |
Ejemplares similares
-
Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Hu, Sigan, et al.
Publicado: (2018) -
NLRP3 inflammasome in peripheral blood monocytes as a risk factor for early -onset preeclampsia
por: Yang, Hong, et al.
Publicado: (2023) -
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
por: Chen, Ao, et al.
Publicado: (2021) -
NLRP3 Inflammasome Activation in Peripheral Arterial Disease
por: Bartoli‐Leonard, Francesca, et al.
Publicado: (2023) -
Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
por: Gritsenko, Anna, et al.
Publicado: (2020)